AVIENCE — Avience Biomedicals Share Price
Last trade - 00:00- IN₹1.37bn
- IN₹1.61bn
- IN₹525.06m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.37 | ||
| Price to Tang. Book | 4.39 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.03 | ||
| EV to EBITDA | 14.12 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 23.4% | ||
| Return on Equity | 37.74% | ||
| Operating Margin | 23.27% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 101.47 | 109.21 | 239.64 | 452.36 | 525.06 | n/a | n/a | 50.82% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +8.86 | +175.41 | +232.76 | +67.46 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Avience Biomedicals Limited is an India-based medical consumables company. The Company is focused on manufacturing of in vitro-diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India. Its diversified product portfolio can primarily be divided into two main categories: manufacturing of medical consumables, and distribution of branded equipment. Its product categories include rapid cards, biochemistry, molecular, hematology, biochemistry regent, oxygen concentrator, culture media, plastic ware, cleaning solution, and other lab equipment. Its rapid test kit products include Avisure Pregnancy Card, Avisure Dengue Ns1 Antigen Rapid Test Kit, and Avisure Malaria Antigen Pf Pan Rapid Test Kit. Its molecular test products include H1N1 Swine Flu, and Covid Detection Kit. Its culture media products include Avienbio Chocolate Agar Plate, and Avienbio Cled Agar Bottle. Its electrolyte reagents include Avienbio Ez-Cleanser 10ml and Avienbio Multi Biosensor Module Av 80.
Directors
- Dharam Choudhary CHM (58)
- Ram Choudhary EDR (46)
- Deepa Choudhary EDR (37)
- Janardan Pal NED (43)
- Om Pal IND (55)
- Pankaj Sharma IND (52)
- Saurabh Verma CFO (33)
- Manoj Kumar CCO (42)
- Last Annual
- March 31st, 2026
- Last Interim
- March 31st, 2025
- Incorporated
- December 23rd, 2019
- Public Since
- June 25th, 2026
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 5,485,056
- Address
- Janakpuri A-3, NEW DELHI, 110058
- Web
- https://avienbio.com
- Phone
- +91 18001204636
- Auditors
- Haribhakti & Co. LLP
Similar to AVIENCE
Borosil Scientific
National Stock Exchange of India
Entero Healthcare Solutions
National Stock Exchange of India
Fischer Medical Ventures
National Stock Exchange of India
Galaxy Medicare
National Stock Exchange of India
GKB Ophthalmics
National Stock Exchange of India
FAQ
As of Today at 09:28 UTC, shares in Avience Biomedicals are trading at IN₹250.00. This share price information is delayed by 15 minutes.
Shares in Avience Biomedicals last closed at IN₹250.00 and the price had moved by over the past 365 days. In terms of relative price strength the Avience Biomedicals share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreAvience Biomedicals does not currently pay a dividend.
Avience Biomedicals does not currently pay a dividend.
Avience Biomedicals does not currently pay a dividend.
To buy shares in Avience Biomedicals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹250.00, shares in Avience Biomedicals had a market capitalisation of IN₹1.37bn.
Here are the trading details for Avience Biomedicals:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: AVIENCE
Based on an overall assessment of its quality, value and momentum Avience Biomedicals is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Avience Biomedicals. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹250.00, shares in Avience Biomedicals were trading -12.05% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Avience Biomedicals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹250.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Avience Biomedicals' management team is headed by:
- Dharam Choudhary - CHM
- Ram Choudhary - EDR
- Deepa Choudhary - EDR
- Janardan Pal - NED
- Om Pal - IND
- Pankaj Sharma - IND
- Saurabh Verma - CFO
- Manoj Kumar - CCO